Cargando…

Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study

INTRODUCTION: In resource-limited settings, the mortality rate among tuberculosis and human Immunodeficiency virus co-infected children is higher. However, there is no adequate evidence in Ethiopia in general and in the study area in particular. Hence, this study aims to estimate lifetime survival a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chanie, Ermias Sisay, Gelaye, Getnet Asmare, Tadesse, Tesfaye Yimer, feleke, Dejen Getaneh, Admas, Wubet Taklual, Molla Alemu, Eshetie, Azanaw, Melkalem Mamoye, Tiruneh, Sofonyas Abebaw, Gebremariam, Alemayehu Digssie, Birhane, Binyam Minuye, Bayih, Wubet Alebachew, Aragie, Getachew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691625/
https://www.ncbi.nlm.nih.gov/pubmed/34932563
http://dx.doi.org/10.1371/journal.pone.0258964
_version_ 1784618802043944960
author Chanie, Ermias Sisay
Gelaye, Getnet Asmare
Tadesse, Tesfaye Yimer
feleke, Dejen Getaneh
Admas, Wubet Taklual
Molla Alemu, Eshetie
Azanaw, Melkalem Mamoye
Tiruneh, Sofonyas Abebaw
Gebremariam, Alemayehu Digssie
Birhane, Binyam Minuye
Bayih, Wubet Alebachew
Aragie, Getachew
author_facet Chanie, Ermias Sisay
Gelaye, Getnet Asmare
Tadesse, Tesfaye Yimer
feleke, Dejen Getaneh
Admas, Wubet Taklual
Molla Alemu, Eshetie
Azanaw, Melkalem Mamoye
Tiruneh, Sofonyas Abebaw
Gebremariam, Alemayehu Digssie
Birhane, Binyam Minuye
Bayih, Wubet Alebachew
Aragie, Getachew
author_sort Chanie, Ermias Sisay
collection PubMed
description INTRODUCTION: In resource-limited settings, the mortality rate among tuberculosis and human Immunodeficiency virus co-infected children is higher. However, there is no adequate evidence in Ethiopia in general and in the study area in particular. Hence, this study aims to estimate lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest Ethiopia Hospitals, 2021. METHODS: Institution-based historical follow-up study was conducted in Northwest Ethiopia Hospitals among 227 Tuberculosis and Human Immunodeficiency Virus co-infected children from March 1, 2014, to January 12, 2021. The data were entered into Epi info-7 and then exported to STATA version 14 for analysis. The log-rank test was used to estimate the curve difference of the predictor variables. Bivariable cox-proportional hazard models were employed for each predictor variable. Additionally, those variables having a p-value < 0.25 in bivariate analysis were fitted into a multivariable cox-proportional hazards model. P-value < 0.05 was used to declare significance associated with the dependent variable. RESULTS: From a total of 227 TB and HIV co-infected children, 39 died during the follow-up period. The overall mortality rate was 3.7 (95% CI (confidence interval): 2.9–4.7) per 100 person-years with a total of 1063.2-year observations. Cotrimoxazole preventive therapy (CPT) non-users [Adjusted Hazarded Ratio (AHR) = 3.8 (95% CI: 1.64–8.86)], presence of treatment failure [AHR = 3.0 (95% CI: 1.14–78.17)], and Cluster of differentiation 4(CD4) count below threshold [AHR = 2.7 (95% CI: 1.21–6.45)] were significant predictors of mortality. CONCLUSION: In this study, the mortality rate among TB and HIV co-infected children was found to be very high. The risk of mortality among TB and HIV co-infected children was associated with treatment failure, CD4 count below the threshold, and cotrimoxazole preventive therapy non-users. Further research should conduct to assess and improve the quality of ART service in Northwest Ethiopia Hospitals.
format Online
Article
Text
id pubmed-8691625
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86916252021-12-22 Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study Chanie, Ermias Sisay Gelaye, Getnet Asmare Tadesse, Tesfaye Yimer feleke, Dejen Getaneh Admas, Wubet Taklual Molla Alemu, Eshetie Azanaw, Melkalem Mamoye Tiruneh, Sofonyas Abebaw Gebremariam, Alemayehu Digssie Birhane, Binyam Minuye Bayih, Wubet Alebachew Aragie, Getachew PLoS One Research Article INTRODUCTION: In resource-limited settings, the mortality rate among tuberculosis and human Immunodeficiency virus co-infected children is higher. However, there is no adequate evidence in Ethiopia in general and in the study area in particular. Hence, this study aims to estimate lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest Ethiopia Hospitals, 2021. METHODS: Institution-based historical follow-up study was conducted in Northwest Ethiopia Hospitals among 227 Tuberculosis and Human Immunodeficiency Virus co-infected children from March 1, 2014, to January 12, 2021. The data were entered into Epi info-7 and then exported to STATA version 14 for analysis. The log-rank test was used to estimate the curve difference of the predictor variables. Bivariable cox-proportional hazard models were employed for each predictor variable. Additionally, those variables having a p-value < 0.25 in bivariate analysis were fitted into a multivariable cox-proportional hazards model. P-value < 0.05 was used to declare significance associated with the dependent variable. RESULTS: From a total of 227 TB and HIV co-infected children, 39 died during the follow-up period. The overall mortality rate was 3.7 (95% CI (confidence interval): 2.9–4.7) per 100 person-years with a total of 1063.2-year observations. Cotrimoxazole preventive therapy (CPT) non-users [Adjusted Hazarded Ratio (AHR) = 3.8 (95% CI: 1.64–8.86)], presence of treatment failure [AHR = 3.0 (95% CI: 1.14–78.17)], and Cluster of differentiation 4(CD4) count below threshold [AHR = 2.7 (95% CI: 1.21–6.45)] were significant predictors of mortality. CONCLUSION: In this study, the mortality rate among TB and HIV co-infected children was found to be very high. The risk of mortality among TB and HIV co-infected children was associated with treatment failure, CD4 count below the threshold, and cotrimoxazole preventive therapy non-users. Further research should conduct to assess and improve the quality of ART service in Northwest Ethiopia Hospitals. Public Library of Science 2021-12-21 /pmc/articles/PMC8691625/ /pubmed/34932563 http://dx.doi.org/10.1371/journal.pone.0258964 Text en © 2021 Chanie et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chanie, Ermias Sisay
Gelaye, Getnet Asmare
Tadesse, Tesfaye Yimer
feleke, Dejen Getaneh
Admas, Wubet Taklual
Molla Alemu, Eshetie
Azanaw, Melkalem Mamoye
Tiruneh, Sofonyas Abebaw
Gebremariam, Alemayehu Digssie
Birhane, Binyam Minuye
Bayih, Wubet Alebachew
Aragie, Getachew
Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title_full Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title_fullStr Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title_full_unstemmed Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title_short Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study
title_sort estimation of lifetime survival and predictors of mortality among tb with hiv co-infected children after test and treat strategies launched in northwest, ethiopia, 2021; a multicentre historical follow-up study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691625/
https://www.ncbi.nlm.nih.gov/pubmed/34932563
http://dx.doi.org/10.1371/journal.pone.0258964
work_keys_str_mv AT chanieermiassisay estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT gelayegetnetasmare estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT tadessetesfayeyimer estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT felekedejengetaneh estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT admaswubettaklual estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT mollaalemueshetie estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT azanawmelkalemmamoye estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT tirunehsofonyasabebaw estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT gebremariamalemayehudigssie estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT birhanebinyamminuye estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT bayihwubetalebachew estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy
AT aragiegetachew estimationoflifetimesurvivalandpredictorsofmortalityamongtbwithhivcoinfectedchildrenaftertestandtreatstrategieslaunchedinnorthwestethiopia2021amulticentrehistoricalfollowupstudy